ArticleBMJ open2025

Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial.

Rosa Klotz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.